The distribution of TTO of ICI-P cases (Figure 2E) and ICI-DM cases (Figure 2F) was roughly the same as that of total pancreatic AE cases following ICIs treatments except for anti-CTLA-4. The gene discussed is CTLA4; the disease is acrodermatitis enteropathica.